Hashdex is shutting down its $14.7 million Bitcoin ETF, DEFI, after trading and creation orders ended on Aug. 17. The closure, announced Aug. 3, comes as the fund's net assets proved too small to justify operating costs. The last day of trading on NYSE Arca was Aug. 17, and the fund will now liquidate its remaining Bitcoin and wind up operations.
Why the fund is closing
Hashdex said the decision came down to the asset base, trading liquidity, operating costs, investor interest, and product fit. The formal liquidation plan was blunter: DEFI's net assets relative to operating expenses made it unreasonable and imprudent to continue the fund over the long term.
The numbers back that up. As of July 30, DEFI held $14.7 million in assets. BlackRock's IBIT, by contrast, had $48.07 billion in net assets as of Aug. 5 — more than 3,000 times DEFI's snapshot. On Aug. 18, the day after DEFI's last trade, other U.S. Bitcoin products saw $189.3 million in net inflows, with IBIT alone pulling in $143.6 million.
What holders get
Remaining DEFI holders won't get a fixed payout. They'll receive a cash distribution based on the fund's net asset value during liquidation, which means the final amount could be affected by closing costs and Bitcoin price movements between now and the distribution date.
There's also a wrinkle in the timeline. The public announcement says the distribution will happen on or about Aug. 28, but the SEC filing says on or about Aug. 24. Hashdex noted the date could change.
Not a broader retreat
The closure applies only to DEFI. Hashdex's other U.S. products, including NCIQ, are unaffected, and the firm continues to manage over $200 million in U.S. products. This is a targeted cleanup of a fund that never gained traction, not a signal that the issuer is leaving the space.
The next concrete step is the cash distribution to DEFI holders, expected around Aug. 24 or Aug. 28 depending on which filing you read. Until then, the fund's remaining Bitcoin sits in limbo, subject to the same price swings that made its economics so difficult in the first place.
